A carregar...
Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents
Warfarin was the only oral anticoagulant available for the treatment of venous thromboembolism for about half a century until the recent approval of novel oral agents dabigatran, rivoraxaban and apixaban. This presents new classes of medications less cumbersome to use. They do not require frequent l...
Na minha lista:
| Publicado no: | Curr Drug ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bentham Science Publishers
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5003057/ https://ncbi.nlm.nih.gov/pubmed/27594818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1574885511666160421145036 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|